Patents Assigned to Endocrine Pharmaceuticals Limited
  • Proteinaceous compounds
    Patent number: 8367801
    Abstract: A purified novel peptide micrin and its fragments are disclosed. The molecule has hormonal functions and has wide-ranging biological effects. Several uses are disclosed including its therapeutic potential in tissue reduction, tumour suppression, infertility and senescence. A micrin-recognising antibody and the micrin gene are also disclosed.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 5, 2013
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart
  • PROTEINACEOUS COMPOUNDS
    Publication number: 20100292438
    Abstract: A purified novel peptide micrin and its fragments are disclosed. The molecule has hormonal functions and has wide-ranging biological effects. Several uses are disclosed including its therapeutic potential in tissue reduction, tumour suppression, infertility and senescence. A micrin-recognising antibody and the micrin gene are also disclosed.
    Type: Application
    Filed: January 12, 2009
    Publication date: November 18, 2010
    Applicant: ENDOCRINE PHARMACEUTICALS LIMITED
    Inventor: John Ernest Hart
  • Isolated material having an anti-organotrophic effect
    Patent number: 7700132
    Abstract: An endogenous mammalian material has been found which has the biological effect of causing a reduction in the mass of mammalian organs including the heart and prostate. The material has physico-chemical properties such that it appears as a compound of molecular weight between 10 and 20 kD when subjected to a purification process using membrane filtration followed by gel filtration. This material has therapeutic uses including the treatment of organ or tissue hypertrophy and hyperplasia.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: April 20, 2010
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart
  • Isolated material having an anti-organotrophic effect
    Patent number: 7572465
    Abstract: A material having the ability to reduce organ mass has been isolated by collecting ovarian venous blood from a female mammal; preparing ovarian venous plasma from the blood; and at least partially purifying said material from the plasma. This material has therapeutic and other uses, e.g. in the treatment of organ or tissue hypertrophy.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: August 11, 2009
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart